- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Levi & Korsinsky Investigating ICON Public Limited Company Over Securities Fraud Claims
Law firm seeks to recover losses for investors after company delays Q4 2025 earnings release and discloses revenue overstatement.
Feb. 19, 2026 at 3:07pm
Got story updates? Submit your updates here. ›
Levi & Korsinsky, a national securities litigation firm, has commenced an investigation into ICON Public Limited Company (NASDAQ: ICLR) over potential violations of federal securities laws. The investigation follows a significant single-day stock decline after ICON disclosed a preliminary revenue overstatement for fiscal years 2023 and 2024, as well as a delay in releasing its Q4 and full-year 2025 results.
Why it matters
The abrupt sell-off wiped out billions in shareholder value and represents one of the largest percentage drops in the contract research organization (CRO) sector in recent years. The disclosure contradicts ICON's previous statements about its financial performance and trajectory, raising concerns about potential accounting irregularities or misrepresentations to investors.
The details
ICON had previously affirmed its full-year 2025 revenue guidance of $8.05 billion to $8.1 billion and adjusted EPS of $13.00 to $13.20 as recently as October 2025. However, the company now states it has identified a preliminary revenue overstatement of under 2% per year for fiscal 2023 and 2024. This sudden change in ICON's financial outlook prompted a significant sell-off, with the company's stock price plummeting over 30% in a single trading session.
- On February 17, 2026, ICON announced it would delay the release of its Q4 and full-year 2025 results.
- In the quarters prior to the disclosure, ICON had repurchased $750 million of its own stock and approved a new $1 billion buyback authorization, signaling confidence in the company's financial position.
The players
ICON Public Limited Company
A global provider of outsourced drug and device development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organizations.
Levi & Korsinsky LLP
A nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases.
What’s next
Levi & Korsinsky is exploring a potential recovery for investors under federal securities laws. The law firm is encouraging ICON shareholders who suffered losses to contact them to discuss a potential case.
The takeaway
The investigation into ICON Public Limited Company highlights the importance of accurate financial reporting and transparency for publicly traded companies. Investors rely on this information to make informed decisions, and any discrepancies or delays can have significant consequences, as seen in this case.
